Jason Napodano, CFA
Managing Director & Sr. Biotech Analyst, Zacks SCR
CFA
$DEPO under $5. This despite what remains a very nice trajectory for Gralise. I think it's due for a bounce.
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.